Equities researchers at StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
ADXS stock opened at $0.02 on Tuesday. The stock has a market cap of $852,660.00, a price-to-earnings ratio of 0.00 and a beta of 1.56. The company has a 50 day simple moving average of $0.18 and a 200 day simple moving average of $0.47. Ayala Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $1.49.
About Ayala Pharmaceuticals
Further Reading
- Five stocks we like better than Ayala Pharmaceuticals
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- What Are Bonds? A High-Level Overview
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Super Micro Stock Drops Sharply After Earnings on Margin Concerns
- Learn Technical Analysis Skills to Master the Stock Market
- Lyft’s First-Ever Profit, but the Outlook Is a Speed Bump
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.